Skip to main content

Table 2 Clinical outcomes

From: A high-dose mobility booster program versus usual care for people after stroke: protocol for a pilot randomized trial

Outcome

Measure

Unit

Mobility

• Walking speed: 5-m walk test to measure walking speed, step length and cadence, higher speed indicates better walking [8]

• Walking capacity: 6-min walk test to measure distance covered in 6 min, higher distance indicates better walking capacity [9]

m/s

Total m

Balance

Modified Step Test: number of steps in 15 s on each leg, higher score indicates better balance [10]

# steps

Walking self-efficacy

• Self-rated walking ability, higher score indicates better walking

• Self-reported furthest walking distance, higher distance indicates better walking capacity

• Walking self-efficacy questionnaire, higher score indicating better self-efficacy [11]

VAS 0–10

Total m

0–30

Health status

EuroQol-visual analogue scale (EQ-VAS), a higher number indicating better overall health status [12]

0–100

Community participation

Two purpose-designed questions about number of outings and satisfaction with level of community participation, higher number of outings indicating better community participation [11]

Satisfied (yes/no)

# outings last 2 weeks